|
Volumn 97, Issue 2, 1994, Pages 135-144
|
NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis
a,b,c a,b,d a,b,c a,b,d a,b,e a,b,c a,b,f a,b,g a,b,h a,b,i a,b,j a,b,j a,b,d a,b,d a,b,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
ITRACONAZOLE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ANEMIA;
ANTIFUNGAL ACTIVITY;
ARTICLE;
ASPERGILLOSIS;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FEMALE;
GRANULOCYTOPENIA;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
LIFE EXPECTANCY;
LUNG DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
MORTALITY;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RELAPSE;
THROMBOCYTOPENIA;
ADMINISTRATION, ORAL;
AGRANULOCYTOSIS;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ASPERGILLOSIS;
CENTRAL NERVOUS SYSTEM DISEASES;
CHI-SQUARE DISTRIBUTION;
FEMALE;
HUMANS;
ITRACONAZOLE;
MALE;
MIDDLE AGED;
ORGAN TRANSPLANTATION;
RECURRENCE;
RESPIRATORY TRACT INFECTIONS;
TREATMENT OUTCOME;
|
EID: 0028029402
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/0002-9343(94)90023-X Document Type: Article |
Times cited : (471)
|
References (20)
|